2 Xideas Ag Catalent, Inc. Transaction History

2 Xideas Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1.41 Million - $2.2 Million	-19,427 Reduced 16.64%	97,305 $7.04 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $706,145 - $923,576	-8,098 Reduced 6.49%	116,732 $12.5 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $1.26 Million - $1.67 Million	13,422 Added 12.05%	124,830 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $1.05 Million - $1.22 Million	8,781 Added 8.56%	111,408 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $1.61 Million - $2.1 Million	14,769 Added 16.81%	102,627 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $595,718 - $686,851	5,937 Added 7.25%	87,858 $9.5 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $1.25 Million - $1.54 Million	12,325 Added 17.71%	81,921 $8.63 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $5.98 Million - $7.33 Million	69,596 New	69,596 $7.24 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

Stay updated on 2 Xideas Ag with notifications on news.